1.
Навашин С.М., Чучалин А.Г., Белоусов Ю.Б. и др. Антибактериальная терапия пневмоний у взрослых. Учебно-методическое пособие для врачей. Москва: РМВести; 1998. 28 с.
2.
Страчунский Л.С., Козлов С.Н. Современная антимикробная химиотерапия. Руководство для врачей. Москва: Боргес; 2002.
3.
Практическое руководство по антиинфекционной химиотерапии. Под ред. Л.С. Страчунского, Ю.Б. Белоусова, С.Н. Козлова. Москва: Боргес; 2002.
4.
Яковлев С.В. Антимикробная химиотерапия. Москва: АО «Фармарус»; 1997. 188 с.
5.
Козлов Р.С., Кречикова О.И., Сивая О.В. и др. Антимикробная резистентность Streptococcus pneumoniae в России: результаты проспективного многоцентрового исследования (фаза А проекта ПеГАС-I). КМАХ 2002;4(3):267-77.
6.
Mandell L.A., Niederman M. and Canadian Community-Acquired Pneumonia Consensus Conference Group. Antimicrobial treatment of community-acquired pneumonia in adults: a conference report. Can J Infect Dis 1993;4:25-2.
7.
Huchon G., Woodhead M. and the ERS Task Force. Guidelines for management of adult communityacquired lower respiratory tract infections. Eur Respir J 1998; 11:986-91.
8.
Bartlett J.G., Breiman R.F., Mandell L.A., File T.M. Jr. Communityacquired pneumonia in adults: guidelines for management. Clin Infect Dis 1998;26:811-38.
9.
Bartlett J.G., Dowell S.F., Mandell L.A., File T.M. Jr., Musher D.M., Fine M.J. Practice guidelines for the management of communityacquired pneumonia in adults. Clin Infect Dis 2000;31:347-82.
10.
Mandell L.A., Marrie T.J., Grossman R.F., Chow A.W., Hyland R.H., the Canadian Community-Acquired Pneumonia Working Group. Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society. Clin Infect Dis 2000; 31:383-421.
11.
Heffelfinger J.D., Dowell S.F., Jorgensen J.H., et al. Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the DrugResistant S. pneumoniae Therapeutic Working Group. Arch Intern Med 2000;160:1399-408.
12.
Niederman M.S., Mandell L.A., Anzueto A., et al. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 2001;163:1730-54.
13.
British Thoracic Society Guidelines for the management of communityacquired pneumonia in adults. Thorax 2001; 56 Suppl. 4:1-64.
14.
Centers for Disease Control and Prevention. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). Mortal Morbid Wkly Rep 1997;46 (R-8)
15.
Prevention and Control of Influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). Mortal. Morbid. Wkly Rep. 2001;50 (№ RR4).
16.
Low D.E. Trends and significance of antimicrobial resistance in respiratory pathogens. Curr Opin Infect Dis 2000;13:145-53.
17.
Klugman K.P., Feldman C. S. pneumoniae respiratory tract infectious. Curr Opin Infect Dis 2001;14:173-9.
18.
Metlay J.P. Update of communityacquired pneumonia: impact of antibiotic resistance on clinical outcomes. Curr Opin Infect Dis 2002;15:163-7.
19.
Andes D. Pharmacokinetic and pharmacodynamic properties of antimicrobials in the therapy of respiratory tract infectious. Curr Opin Infect Dis 2001; 14:165-72.
20.
Metlay J. P., Fine M.J. Testing Strategies in the Initial Management of Patient with Community-Acquired Pneumonia. Ann Intern Med 2003; 138:109-18.
21.
Fine M.J., Smith M.A., Carson C.A., et al. Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis. JAMA 1996; 275:134-41.